{"id":"human-soluble-insulin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin is a naturally occurring hormone that regulates blood glucose by binding to insulin receptors on muscle, fat, and liver cells, facilitating glucose transport into these cells and promoting its storage as glycogen or conversion to fat. This mechanism mimics the body's endogenous insulin response to maintain normal blood glucose homeostasis. Human soluble insulin is a rapid-acting formulation designed for subcutaneous injection to manage hyperglycemia in diabetic patients.","oneSentence":"Human soluble insulin binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:23:22.902Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT02728635","phase":"NA","title":"Epigenetic Regulation of Human Adipose Tissue Distribution","status":"ACTIVE_NOT_RECRUITING","sponsor":"AdventHealth Translational Research Institute","startDate":"2016-07","conditions":"Obesity","enrollment":27},{"nctId":"NCT07466173","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight","status":"NOT_YET_RECRUITING","sponsor":"University of Ulm","startDate":"2026-04","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT02846571","phase":"PHASE1, PHASE2","title":"Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye","status":"RECRUITING","sponsor":"Midhat H. Abdulreda","startDate":"2019-12-05","conditions":"Diabetes","enrollment":2},{"nctId":"NCT06334133","phase":"PHASE3","title":"Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes","status":"RECRUITING","sponsor":"vTv Therapeutics","startDate":"2024-06-14","conditions":"Diabetes Mellitus, Type 1","enrollment":150},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT07461103","phase":"PHASE2","title":"Effect of Topical Insulin on Healing Rate of Pemphigus Lesions","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-06-22","conditions":"Pemphigus Vulgaris, Skin Erosion, Autoimmune Blistering Disease","enrollment":20},{"nctId":"NCT03366168","phase":"","title":"Taste Bud-Derived Stem Cells in Humans","status":"RECRUITING","sponsor":"National Institute on Aging (NIA)","startDate":"2017-12-18","conditions":"Diabetes","enrollment":250},{"nctId":"NCT05539872","phase":"PHASE2, PHASE3","title":"Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2022-08-22","conditions":"Pharmacokinetics, Pharmacodynamics","enrollment":69},{"nctId":"NCT00743782","phase":"PHASE2","title":"Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2008-08-22","conditions":"Hypoparathyroidism, Hypocalcemia, Autoimmune Polyendocrine Syndrome Type 1","enrollment":21},{"nctId":"NCT02653092","phase":"NA","title":"Reprometabolic Syndrome Mediates Subfertility in Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2016-06","conditions":"Obesity, Infertility, Hypogonadotropic Hypogonadotropism","enrollment":84},{"nctId":"NCT07432581","phase":"NA","title":"Topical Insulin Dressing on Management of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-01-01","conditions":"Topical, Insulin, Dressing","enrollment":30},{"nctId":"NCT05018585","phase":"PHASE3","title":"A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diamyd Medical AB","startDate":"2022-05-19","conditions":"Type 1 Diabetes Mellitus","enrollment":330},{"nctId":"NCT07223333","phase":"PHASE1","title":"A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers","status":"RECRUITING","sponsor":"AdipoPharma LLC","startDate":"2026-01-27","conditions":"Type 2 Diabetes","enrollment":56},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT05958706","phase":"","title":"Mitochondrial Substrate Utilization in the Diabetic Human Heart","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2021-12-01","conditions":"Heart Failure, Type2diabetes, Insulin Resistance","enrollment":500},{"nctId":"NCT06295640","phase":"NA","title":"Relative Contribution of Brain Insulin Action for Postprandial Metabolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-03-18","conditions":"Glucose Metabolism Disorders","enrollment":31},{"nctId":"NCT07403604","phase":"PHASE1","title":"Effect of Insulin Lowering on Lipogenesis","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-04","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":25},{"nctId":"NCT06558422","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Pancreatic Clamp","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2027-01-01","conditions":"Insulin Resistance, Hyperinsulinemia, Metabolic Dysfunction Associated Steatotic Liver Disease","enrollment":36},{"nctId":"NCT07246421","phase":"NA","title":"Glucagon Resistance in Patients With MASLD and T2DM","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2026-01-29","conditions":"Metabolic Associated Fatty Liver Disease, Type 2 Diabetes (T2DM)","enrollment":24},{"nctId":"NCT04666636","phase":"PHASE2","title":"Mechanisms for Activation of Beige Adipose Tissue in Humans","status":"RECRUITING","sponsor":"Philip Kern","startDate":"2020-12-07","conditions":"PreDiabetes","enrollment":65},{"nctId":"NCT04232566","phase":"","title":"Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-02-20","conditions":"Obesity, Morbid, NASH - Nonalcoholic Steatohepatitis, Chronic Inflammation","enrollment":60},{"nctId":"NCT05743868","phase":"NA","title":"Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-11-16","conditions":"Insulin Resistance, Hypertriglyceridemia","enrollment":40},{"nctId":"NCT07364669","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Pisa S.A. de C.V.","startDate":"2024-10-24","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT05670951","phase":"PHASE3","title":"Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants","status":"RECRUITING","sponsor":"Elgan Pharma Ltd.","startDate":"2025-02-27","conditions":"Intestinal Malabsorption","enrollment":360},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT07341373","phase":"PHASE1","title":"A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500","status":"RECRUITING","sponsor":"Portal Diabetes, Inc.","startDate":"2026-01","conditions":"Type 1 Diabetes","enrollment":25},{"nctId":"NCT07336914","phase":"NA","title":"Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-10-01","conditions":"Gestational Diabetes","enrollment":60},{"nctId":"NCT05724134","phase":"PHASE1","title":"Pancreatic Clamp in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-29","conditions":"Insulin Resistance, Prediabetic State, Hyperinsulinemia","enrollment":18},{"nctId":"NCT05305287","phase":"PHASE4","title":"Quantifying Hepatic Mitochondrial Fluxes in Humans","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2022-11-01","conditions":"Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Mitochondrial Metabolism Disorders","enrollment":60},{"nctId":"NCT04809688","phase":"NA","title":"Saskatoon Berry on Metabolism and Gut Microbiota in Healthy Subjects","status":"ENROLLING_BY_INVITATION","sponsor":"University of Manitoba","startDate":"2023-01-08","conditions":"Nutritional and Metabolic Diseases","enrollment":20},{"nctId":"NCT07327684","phase":"NA","title":"Photoacoustic/Ultrasound Imaging of Brown Adipose Tissue Activity","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-05-22","conditions":"Insulin Resistance, Metabolic Syndrome","enrollment":100},{"nctId":"NCT07316582","phase":"PHASE4","title":"Melatonin Loaded in Injectable Platelet-Rich Fibrin in the Management Periodontitis","status":"ENROLLING_BY_INVITATION","sponsor":"Al-Azhar University","startDate":"2025-11-01","conditions":"Periodontitis Stage II","enrollment":60},{"nctId":"NCT07051681","phase":"","title":"Gestational Diabetes and Human Milk Composition Study","status":"COMPLETED","sponsor":"Marmara University","startDate":"2023-12-01","conditions":"Gestational Diabetes Mellitus (GDM)","enrollment":40},{"nctId":"NCT07296991","phase":"NA","title":"VR Stimulation of Exercise Response in Sedentary Humans","status":"RECRUITING","sponsor":"Wayne State University","startDate":"2025-09-30","conditions":"Prolonged Inactivity, Metabolic Syndrome","enrollment":48},{"nctId":"NCT05153395","phase":"EARLY_PHASE1","title":"Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation","status":"SUSPENDED","sponsor":"University of Missouri-Columbia","startDate":"2021-12-01","conditions":"Healthy, Vasodilation, Insulin Resistance","enrollment":65},{"nctId":"NCT07128368","phase":"NA","title":"Mechanisms of Resistance Exercise Training for Improved Muscle Insulin Sensitivity","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-09-01","conditions":"Resistance Training","enrollment":16},{"nctId":"NCT06606327","phase":"PHASE1","title":"Diazoxide Suppression Test P&F Study","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-10-23","conditions":"Insulin Resistance, Hyperinsulinemia, Obesity","enrollment":10},{"nctId":"NCT06552130","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-12-15","conditions":"Insulin Sensitivity","enrollment":20},{"nctId":"NCT06592261","phase":"PHASE1","title":"Graded Insulin Suppression Test P&F","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-09-16","conditions":"Insulin Resistance, Hyperinsulinemia, Obesity","enrollment":15},{"nctId":"NCT06354088","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Alpelisib, Part I","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-04-24","conditions":"Insulin Resistance, Prediabetic State, Overweight and Obesity","enrollment":32},{"nctId":"NCT05220917","phase":"","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-08-01","conditions":"Cardiovascular Events, Type2 Diabetes, Renal Disease","enrollment":781430},{"nctId":"NCT06776094","phase":"NA","title":"Physical Activity and Insulin Sensitivity Dynamics","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-05-05","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT07255807","phase":"NA","title":"Defining the Human Insulin Resistance Molecular Network; SIGNATURE","status":"NOT_YET_RECRUITING","sponsor":"University of Copenhagen","startDate":"2025-12-01","conditions":"Metabolic Health, Insulin Sensitivity/Resistance","enrollment":80},{"nctId":"NCT06638190","phase":"NA","title":"Influence of the Fruit Matrix on Glucose and Insulin Responses After the Intake of Orange Juice in Healthy Human Males","status":"COMPLETED","sponsor":"María-Teresa García-Conesa","startDate":"2024-10-21","conditions":"Healthy Nutrition","enrollment":25},{"nctId":"NCT04158375","phase":"NA","title":"Molecular Mechanisms of Exercise Benefits to Insulin Resistant People","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-09-02","conditions":"Insulin Resistance, Obesity","enrollment":58},{"nctId":"NCT05259449","phase":"NA","title":"Efficacy of Educational Nutrition and Exercise on the Regulation of Appetite Through Exosomes in Type 2 Diabetics","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cadiz","startDate":"2022-03-10","conditions":"Diabetes Mellitus, Type 2","enrollment":146},{"nctId":"NCT05831709","phase":"NA","title":"The Influence of Hormone Replacement Therapy and Supervised Exercise Training on Body Composition, Cardiovascular Risk and Insulin Sensitivity in Postmenopausal Women","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2023-05-12","conditions":"Postmenopause, Menopausal Complaints","enrollment":390},{"nctId":"NCT01909245","phase":"PHASE2","title":"Islet Cell Transplant for Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2013-10-16","conditions":"Type 1 Diabetes Mellitus","enrollment":10},{"nctId":"NCT06655740","phase":"NA","title":"Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aqua Medical, Inc.","startDate":"2024-10-01","conditions":"Diabetes Mellitus, Type 2","enrollment":16},{"nctId":"NCT06967701","phase":"NA","title":"Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-07-10","conditions":"Type 1 Diabetes (T1D), Latent Autoimmune Diabetes in Adult (LADA), Pancreatitis","enrollment":60},{"nctId":"NCT04352244","phase":"","title":"The Physiology of Human Brown Adipose Tissue","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2020-03-05","conditions":"Adipose Tissue, Brown, Adipose Tissue, Obesity","enrollment":40},{"nctId":"NCT06923839","phase":"PHASE1","title":"Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oluf Pedersen","startDate":"2025-07-28","conditions":"Healthy Male Adults","enrollment":15},{"nctId":"NCT07172672","phase":"NA","title":"The TiMeD-T1D Project","status":"NOT_YET_RECRUITING","sponsor":"University of Aarhus","startDate":"2025-11-01","conditions":"Postprandial Lipid Metabolism, Type 1 Diabetes (T1D)","enrollment":10},{"nctId":"NCT04528693","phase":"NA","title":"The Effect of 12-week Circuit Training on Insulin Sensitivity and Endothelial Function in Women With Insulin Resistance","status":"COMPLETED","sponsor":"Poznan University of Physical Education","startDate":"2020-08-17","conditions":"Insulin Resistance","enrollment":49},{"nctId":"NCT07178353","phase":"NA","title":"Human Skeletal Muscle Response to 5 Days of Bedrest in Young Adults","status":"RECRUITING","sponsor":"Queen's University","startDate":"2025-09","conditions":"Muscular Atrophy, Insulin Resistance, Muscle Protein Synthesis","enrollment":12},{"nctId":"NCT05614089","phase":"PHASE4","title":"Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings","status":"COMPLETED","sponsor":"Jing Luo","startDate":"2023-03-15","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes","enrollment":400},{"nctId":"NCT05988632","phase":"PHASE1, PHASE2","title":"Intranasal Insulin for Treatment of Alcohol Use Disorder","status":"RECRUITING","sponsor":"Brown University","startDate":"2025-02-25","conditions":"Alcohol Use Disorder","enrollment":40},{"nctId":"NCT05904626","phase":"PHASE2","title":"Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA","status":"NOT_YET_RECRUITING","sponsor":"Elgan Pharma Ltd.","startDate":"2025-09","conditions":"Intestinal Malabsorption","enrollment":60},{"nctId":"NCT07141472","phase":"NA","title":"Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study","status":"COMPLETED","sponsor":"Lawry Han","startDate":"2025-01-07","conditions":"Blood Sugar; High, Overweight and Obesity, Fat Loss","enrollment":69},{"nctId":"NCT01493934","phase":"PHASE1, PHASE2","title":"Development of a Fast Measurement Technique of Insulin Resistance in Human","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2010-04","conditions":"Type 2 Diabetes Mellitus","enrollment":12},{"nctId":"NCT07104461","phase":"NA","title":"Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity","status":"COMPLETED","sponsor":"University of Westminster","startDate":"2023-06-09","conditions":"Appetite and General Nutritional Disorders","enrollment":12},{"nctId":"NCT06074003","phase":"NA","title":"Does Biological Sex Influence Insulin Sensitivity and Muscle Metabolism Following High-intensity Interval Exercise?","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2023-10-15","conditions":"Exercise","enrollment":24},{"nctId":"NCT02244073","phase":"NA","title":"Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2015-05","conditions":"Critical Illness","enrollment":2069},{"nctId":"NCT06280625","phase":"NA","title":"The Effect of the Inclusion of Soybean Flour on Glycemic Responses","status":"TERMINATED","sponsor":"University of Illinois at Urbana-Champaign","startDate":"2024-03-11","conditions":"Overweight and Obesity","enrollment":17},{"nctId":"NCT06081387","phase":"NA","title":"The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment","status":"RECRUITING","sponsor":"University Ramon Llull","startDate":"2025-10-01","conditions":"Diabetes Mellitus, Type 2","enrollment":80},{"nctId":"NCT06717191","phase":"PHASE4","title":"Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan","status":"COMPLETED","sponsor":"Life for a Child Program, Diabetes Australia","startDate":"2022-06-09","conditions":"Type 1 Diabetes","enrollment":296},{"nctId":"NCT03241706","phase":"PHASE1","title":"Liver Glycogen and Hypoglycemia in Humans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jason Winnick","startDate":"2018-08-02","conditions":"Hypoglycemia; Iatrogenic","enrollment":40},{"nctId":"NCT05718089","phase":"NA","title":"Precision Exercise Therapeutics (PET-pilot)","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2023-03-01","conditions":"Overweight, Healthy","enrollment":24},{"nctId":"NCT02879409","phase":"NA","title":"HbA1c Variability in Type II Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Cornell Medical College in Qatar","startDate":"2016-11","conditions":"Diabetes Mellitus Type 2","enrollment":150},{"nctId":"NCT01047735","phase":"NA","title":"The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2009-09-01","conditions":"Type 2 Diabetes Mellitus, Obesity","enrollment":69},{"nctId":"NCT07031752","phase":"NA","title":"Plant-Based Meat Analogues and Human Health","status":"COMPLETED","sponsor":"Universidad de Extremadura","startDate":"2022-02-06","conditions":"Satiation, Satiety, Insulin, Glucose","enrollment":25},{"nctId":"NCT06080594","phase":"NA","title":"Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2024-09-22","conditions":"Mitochondrial Myopathies, Mitochondrial Diseases, Mitochondrial Disorders","enrollment":11},{"nctId":"NCT06080581","phase":"","title":"Mitochondrial Dysfunctions Driving Insulin Resistance","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2023-10-20","conditions":"Mitochondrial Myopathies, Mitochondrial Diseases, Mitochondrial Disorders","enrollment":30},{"nctId":"NCT05291845","phase":"PHASE2","title":"Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts","status":"RECRUITING","sponsor":"Zagazig University","startDate":"2022-04-03","conditions":"Warts, Human Papilloma Virus","enrollment":162},{"nctId":"NCT04262479","phase":"PHASE2","title":"Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2020-03-02","conditions":"Latent Autoimmune Diabetes in Adults","enrollment":14},{"nctId":"NCT07007130","phase":"NA","title":"Effect of Intraperitoneal Insulin Administration After Laparoscopy in Insulin-Resistant Patients on Prevention of Postoperative Adhesion Recurrence: A Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-06-01","conditions":"Prevention of Postoperative Adhesions","enrollment":100},{"nctId":"NCT05776862","phase":"PHASE2","title":"Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)","status":"COMPLETED","sponsor":"University of Miami","startDate":"2023-03-27","conditions":"Spinal Cord Injuries, Tetraplegia, Paraplegia","enrollment":10},{"nctId":"NCT06519604","phase":"PHASE1","title":"Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-07-17","conditions":"Diabete Mellitus","enrollment":20},{"nctId":"NCT04267705","phase":"NA","title":"Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human","status":"ACTIVE_NOT_RECRUITING","sponsor":"Clinical Nutrition Research Center, Illinois Institute of Technology","startDate":"2020-02-24","conditions":"Insulin Sensitivity, Overweight or Obesity, Inflammatory Response","enrollment":103},{"nctId":"NCT02507583","phase":"PHASE1","title":"Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma","status":"COMPLETED","sponsor":"david andrews","startDate":"2015-09-01","conditions":"Malignant Glioma, Neoplasms","enrollment":33},{"nctId":"NCT06956846","phase":"PHASE4","title":"Efficacy of Topical Insuline in Corneal Epithelial Healing Post PRK","status":"NOT_YET_RECRUITING","sponsor":"Hotel Dieu de France Hospital","startDate":"2025-04-25","conditions":"Corneal Epithelial Wound Healing","enrollment":100},{"nctId":"NCT01550523","phase":"PHASE1","title":"Pilot Immunotherapy Trial for Recurrent Malignant Gliomas","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2012-02-09","conditions":"Malignant Glioma of Brain","enrollment":13},{"nctId":"NCT06951074","phase":"PHASE2, PHASE3","title":"Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Stem Cells, Type 1 Diabetes","enrollment":20},{"nctId":"NCT04620590","phase":"PHASE4","title":"Dapagliflozin Treatment in Type 2 Diabetes","status":"COMPLETED","sponsor":"Emerald Clinical Inc.","startDate":"2021-04-20","conditions":"Diabetes Mellitus, Type 2, Impaired Renal Function","enrollment":17},{"nctId":"NCT06939959","phase":"PHASE4","title":"Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.","status":"RECRUITING","sponsor":"Khyber Teaching Hospital","startDate":"2025-04-14","conditions":"Dry Eye, Insulin Sensitivity","enrollment":126},{"nctId":"NCT06938334","phase":"PHASE1, PHASE2","title":"A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Altheia Science","startDate":"2025-08-15","conditions":"Diabetes, Type I","enrollment":15},{"nctId":"NCT06925334","phase":"PHASE4","title":"A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus","status":"ENROLLING_BY_INVITATION","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2024-05-20","conditions":"Type 2 Diabetic Patients","enrollment":170},{"nctId":"NCT05243628","phase":"PHASE4","title":"Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2022-03-31","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT06901726","phase":"PHASE1","title":"Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2025-03-31","conditions":"Diabetes Mellitus","enrollment":10},{"nctId":"NCT06621576","phase":"EARLY_PHASE1","title":"First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2024-09-18","conditions":"Ischaemic Heart Disease, Heart Failure","enrollment":3},{"nctId":"NCT06487832","phase":"NA","title":"Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2024-07-01","conditions":"Normal Weight, Overweight and Obesity, Insulin Sensitivity","enrollment":60},{"nctId":"NCT05662189","phase":"NA","title":"Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus","status":"RECRUITING","sponsor":"Azienda Ospedaliero-Universitaria di Parma","startDate":"2022-03-15","conditions":"Type1diabetes, Type2diabetes, Pre Diabetes","enrollment":70},{"nctId":"NCT02459106","phase":"","title":"Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans","status":"COMPLETED","sponsor":"AdventHealth Translational Research Institute","startDate":"2015-05-27","conditions":"Type 2 Diabetes Mellitus","enrollment":46},{"nctId":"NCT06855615","phase":"PHASE4","title":"Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital Sultanah Aminah Johor Bahru","startDate":"2020-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":44},{"nctId":"NCT00179400","phase":"PHASE4","title":"The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2000-12","conditions":"Type 2 Diabetes Mellitus","enrollment":26},{"nctId":"NCT04496154","phase":"NA","title":"Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry \"Bad Cholesterol\" in the Blood","status":"COMPLETED","sponsor":"May Faraj, PDt, PhD","startDate":"2013-09-05","conditions":"Type 2 Diabetes, Insulin Sensitivity/Resistance, Inflammatory Response","enrollment":41},{"nctId":"NCT06473662","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects","status":"COMPLETED","sponsor":"Roger New","startDate":"2018-10-22","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":153},{"nctId":"NCT02861781","phase":"","title":"Collection of Human Metabolic Tissues","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2016-02-02","conditions":"Obesity, Insulin Resistance, Diabetes Mellitus, Type 2","enrollment":270},{"nctId":"NCT05055804","phase":"NA","title":"The ELG Analysis of Glucose a Correlational to Blood Glucose Assay","status":"ENROLLING_BY_INVITATION","sponsor":"XP Technology, LLC","startDate":"2021-08-11","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":100},{"nctId":"NCT06770608","phase":"PHASE2","title":"Various Procedural Treatment Options for Post-acne Atrophic Scars","status":"NOT_YET_RECRUITING","sponsor":"Sheikh Zayed Medical College","startDate":"2025-01","conditions":"Post-acne Atrophic Scars","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":38,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"human soluble insulin","genericName":"human soluble insulin","companyName":"Novo Nordisk A/S","companyId":"novo-nordisk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Human soluble insulin is a protein that acts as an agonist to the insulin receptor, stimulating its activity. It is used to treat conditions such as Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, and Ovarian Neoplasms, among others.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}